The Dale and Betty Bumpers Vaccine Research Center (VRC) at the National Institutes of Health (NIH) was established to facilitate research in vaccine development. The VRC is dedicated to improving global human health through the rigorous pursuit of effective vaccines for human diseases. Established by former President Bill Clinton as part of an initiative to develop an AIDS vaccine, the VRC is a unique venture within the NIH intramural research program. Initially spearheaded by NIAID, the National Cancer Institute, and the NIH Office of AIDS Research, the VRC is now part of the NIAID organization.
Latest News Releases
Gene-Based Zika Vaccine is Safe and Immunogenic in Healthy Adults, December 4, 2017
NIH Statement on World AIDS Day, December 1, 2017
Three-in-One Antibody Protects Monkeys from HIV-Like Virus, September 20, 2017
The Vaccine Research Center (VRC) is located on the NIH campus in Bethesda, MD, and conducts clinical trials that enroll volunteers to help evaluate vaccines against diseases such as HIV/AIDS, Zika, Ebola, Influenza, and others.